Results 41 to 50 of about 9,865 (187)
An emerging treatment option for glaucoma: Rho kinase inhibitors
Sean K Wang,1 Robert T Chang21Stanford University, Stanford, CA, USA; 2Stanford University School of Medicine, Stanford, CA, USAAbstract: Rho kinase (ROCK) inhibitors are a novel potential class of glaucoma therapeutics with multiple compounds currently ...
Wang SK, Chang RT
doaj
We present a heart‐on‐a‐chip platform embedded with ultrasoft mechanosensors for real‐time, multi‐scale stress mapping in engineered cardiac tissues. The system enables simultaneous quantification of local cell‐generated stresses and global tissue contractile forces.
Ali Mousavi +10 more
wiley +1 more source
Pulmonary fungal infections are life‐threatening complications in lung cancer patients, posing significant challenges in clinical management. To address this, we developed machine learning tools that translate routine electronic health record data into actionable insights for diagnosing infections and assessing prognosis.
Hongwei Meng +14 more
wiley +1 more source
A Case of Palmoplantar Vesiculobullous Lesions
JEADV Clinical Practice, EarlyView.
Ali Abid +3 more
wiley +1 more source
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan +9 more
wiley +1 more source
Abstract Background The oxytocin receptor (OR) is a G‐protein‐coupled receptor recently identified in human spermatozoa, whose origin and role in sperm physiology remain unknown. Objectives In this study, using the pig as a model, we examine the presence of the OR in ejaculated spermatozoa through immunofluorescence and immunoblotting, and investigate ...
Jesús Martínez‐Hernández +9 more
wiley +1 more source
Bullae and Scales in a Newborn
JEADV Clinical Practice, EarlyView.
Hamad El Hajj +3 more
wiley +1 more source
Abstract Purpose This study assesses the PAUL® glaucoma implant (PGI) in primary open angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG) after failed glaucoma surgery. Given PEXG's more aggressive nature, limited research exists on PGI outcomes in this subgroup. This study aims to compare PGI's efficacy and safety in both conditions. Methods A
Constance Liegl +8 more
wiley +1 more source
Canaloplasty in the Treatment of Primary Open-Angle Glaucoma: Patient Selection and Perspectives
Anna Byszewska,1 Joanna Konopińska,2 Aleksandra Kinga Kicińska,1 Zofia Mariak,2 Marek Rękas1 1Department of Ophthalmology, Military Institute of Medicine, Warsaw 04-141, Poland; 2Department of Ophthalmology, Medical University of Białystok, Białystok 15 ...
Byszewska A +4 more
doaj

